X Linked Hypophosphatemia Market

Company Headquarter: ‎ Indianapolis, Indiana, US Founded: 1876 Workforce: 42,066 Company Working: Eli Lilly and Company is an American global pharmaceutical company. The company also has offices in Puerto Rico and 17 other countries. Its products are sold in approximately 125 countries. The company is listed on the New York Stock Exchange, and its shares had been a component of the S&P 500 Index since 1971. Lilly was the first company to mass-produce penicillin, the Salk polio vaccine, and insulin. Its achievements include being one of the first pharmaceutical companies to produce human insulin using recombinant DNA including Humulin, Humalog, and the first approved biosimilar insulin product in the US, Basaglar. Lilly is also the world's largest manufacturer and distributor of psychiatric medications including Prozac (Fluoxetine), Dolophine (Methadone), Cymbalta (Duloxetine), and Zyprexa (olanzapine). Some of the top competitors of Eli Lilly and Company are Pfizer Inc., GlaxoSmithKline PLC, Biogen, Sanofi, and Johnson and Johnson.

Narang Medical Limited is India's most reputed manufacturer and supplier of medical equipment, hospital furniture, orthopedic implants, and instruments. The company’s products are being used in over 80 countries by healthcare providers and patients. It is the only company in India to have the widest range of implants in both stainless steel and titanium medical grade.

Prospec-Tany Technogene Ltd is an evolving biotech company providing highly purified proteins worldwide which serves the research community with cytokine-related products for cancer, apoptosis, development, endocrinology, immunology, neuroscience, proteases, and stem cell research. It also produces bacterial-derived recombinant proteins for the research community in Israel and internationally.

Validus Pharmaceuticals LLC engages in acquiring, reformulating, and marketing prescription products in specialty therapeutic areas. It offers pharmaceutical medications in the areas of psychiatric, neurologic, and other disorders. The company’s business is based on the acquisition of established products that are FDA-approved and satisfy unmet clinical needs.

Ultragenyx Pharmaceutical is a biopharmaceutical company. It focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the US. It also focuses on serious, debilitating metabolic, genetic diseases. The company is led by an experienced management team in rare disease therapeutics.

Company Headquarter: London, UK Founded: 1856 Workforce: 15000 employees Company Working: Smith & Nephew develops and markets medical devices worldwide. The company operates through four segments, namely, sports medicine, trauma, orthopedic reconstruction, and advanced wound management. The company primarily serves the providers of medical and surgical treatments and services. In 2014, Smith & Nephew acquired ArthroCare to broaden its sports medicine segment. The company has also acquired Healthpoint Biotherapeutics, which specializes in the production of bioactive for advanced wound management. Smith & Nephew has its presence in more than 100 countries and has major manufacturing units in the US, the UK, Switzerland, Germany, and China.